We reported a 43-year-old gravida 3 para 2 pregnant woman without underlying disease at 18 weeks' gestationwho presented with fever and chest discomfort. She contacted her husband who visited the boxing stadium where the COVID-19 outbreak occurred and was diagnosed with COVID-19 infection 2 days before she developed symptoms. Her vital signs were normal without fever and physical examination was unremarkable. Nasopharyngeal and throat swabs were positive for SARS-CoV-2 by reverse transcriptase polymerase chain reaction (RT-PCR) assays. Her investigations including complete blood count, renal function, serum electrolyte, liver function and urinalysis were within normal limits. Chest radiograph did not reveal any obvious active cardiopulmonary lesion. Rapid tests for influenza viruses and respiratory syncytial virus were negative. She did not receive any specific treatments due to mild symptoms. Daily fetal heart rate was measured between 120-170 beats per minute. Nasopharyngeal and throat swab were conducted every two days. Her past antenatal history and ultrasonography from another hospital were unremarkable and amniocentesis was done one week before this admission due to high risk of aneuploidy by maternal age. Karyotype results which reported on the 10th day of admission demonstrated 47;XY,+21 and was diagnosed as fetal Down syndrome. Pregnancy termination was decided by the patient and her husband after a meticulous counselling session with an obstetrician. She was clinically improved without fever. After two consecutive
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.